GENE ONLINE|News &
Opinion
Blog

Pfizer
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
If It Works, Replicate It: Generic COVID-19 Drugs
2022-03-28
Alnylam Challenges Moderna and Pfizer with Patent Infringement
2022-03-18
How Did the Russian Invasion of Ukraine Affect Global Biopharma?
2022-03-16
Novartis Bets $1.5 Billion on Voyager’s AAVs
2022-03-09
China’s InxMed Raises $50 Million to Inhibit Cancer-Resisting FAKs
2022-03-07
Pfizer’s RSV Vaccine Bags FDA Breakthrough Therapy Status
2022-03-07
China Gives Conditional Approval to Pfizer’s Covid-19 Oral Antiviral
2022-02-14
FDA to Support Development of Non-Opioid Painkillers
2022-02-11
Pfizer and Alex Therapeutics Ink Partnership for Providing Digital Therapeutics to Patients, Starting in Germany
2022-02-04
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
Pfizer: Pneumonia Shot Can Be Given with COVID-19 Vaccine in Older Adults
2022-01-16
GeneOnline’s Top 10 M&As of 2021
2022-01-11
JPM22 Highlights: Cell and Gene Therapies Rise Up
2022-01-11
FDA Gives Emergency Approval to Merck’s COVID-19 Pill after Giving Similar Nod to Pfizer’s Tablets
2021-12-24
1 2 3 4 5 6 9
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top